Harbor Capital Advisors Inc. Sells 879 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Harbor Capital Advisors Inc. reduced its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 11.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,995 shares of the company’s stock after selling 879 shares during the period. Harbor Capital Advisors Inc.’s holdings in USANA Health Sciences were worth $189,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Pzena Investment Management LLC boosted its holdings in shares of USANA Health Sciences by 3.6% during the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company’s stock worth $39,015,000 after buying an additional 37,466 shares during the period. Dimensional Fund Advisors LP raised its stake in USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after purchasing an additional 55,059 shares during the last quarter. Geode Capital Management LLC raised its stake in USANA Health Sciences by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company’s stock valued at $10,839,000 after purchasing an additional 4,829 shares during the last quarter. American Century Companies Inc. raised its stake in USANA Health Sciences by 12.3% during the 4th quarter. American Century Companies Inc. now owns 233,797 shares of the company’s stock valued at $8,391,000 after purchasing an additional 25,522 shares during the last quarter. Finally, Northern Trust Corp raised its stake in USANA Health Sciences by 16.5% during the 4th quarter. Northern Trust Corp now owns 135,937 shares of the company’s stock valued at $4,879,000 after purchasing an additional 19,266 shares during the last quarter. 54.25% of the stock is owned by institutional investors.

Insider Transactions at USANA Health Sciences

In other USANA Health Sciences news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $29.61, for a total transaction of $134,666.28. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. In the last quarter, insiders have sold 12,013 shares of company stock valued at $360,149. 0.63% of the stock is owned by insiders.

USANA Health Sciences Stock Performance

Shares of USNA stock opened at $29.60 on Monday. USANA Health Sciences, Inc. has a 52-week low of $23.10 and a 52-week high of $48.85. The stock has a market cap of $551.24 million, a price-to-earnings ratio of 10.46, a P/E/G ratio of 0.93 and a beta of 0.63. The firm has a fifty day moving average of $28.04 and a 200-day moving average of $31.03.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, April 22nd. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.70 by $0.03. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $249.54 million during the quarter, compared to analysts’ expectations of $243.08 million. During the same quarter in the prior year, the company posted $0.86 EPS. On average, sell-side analysts predict that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on USNA shares. DA Davidson cut their target price on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday, February 27th. Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th. Finally, Wall Street Zen upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Thursday, May 22nd.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.